Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company was founded in 1988 and is based in Hyderabad, India.
Low
400.00
High
706.00
Low
515.00
High
533.35
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How SAI PARENTERALS LIMITED stacks up against its Drug Manufacturers - General peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SAIPARENT SAI PARENTERALS LIMITED | 522.80 | 1.23% | 106.53 | 4.91 | 2,310 | 0.43% | 28.40% | 706.00 / 400.00 |
| 2 | CORONA CORONA REMEDIES LIMITED | 2,021.10 | 3.45% | 62.11 | 32.54 | 12,412 | 5.96% | 42.93% | 2,292.40 / 1,336.60 |
| 3 | GLAXO GlaxoSmithKline Pharmaceuticals Limited | 2,760.00 | 0.34% | 43.77 | 63.05 | 46,965 | 6.56% | 0.93% | 3,120.70 / 2,088.10 |
| 4 | MARKSANS Marksans Pharma Limited | 323.05 | 0.23% | 28.32 | 11.41 | 14,719 | 1.00% | 90.70% | 350.95 / 155.00 |
| 5 | NGLFINE NGL Fine-Chem Limited | 2,900.00 | 0.33% | 31.27 | 92.73 | 1,792 | 1.19% | 102.51% | 3,602.00 / 1,271.00 |
| 6 | PFIZER Pfizer Limited | 3,857.00 | 0.47% | 24.00 | 160.70 | 17,654 | 20.77% | 25.83% | 5,578.50 / 3,792.10 |
| 7 | RUBICON RUBICON RESEARCH LIMITED | 1,628.00 | 0.53% | 93.28 | 17.45 | 26,949 | 8.34% | 159.03% | 1,899.00 / 570.75 |
| 8 | SANOFI Sanofi India Limited | 3,040.00 | 0.56% | 21.62 | 140.59 | 6,995 | 7.23% | 40.91% | 4,898.00 / 3,001.10 |
| 9 | SANOFICONR SANOFI CONS HEALTHC IND L | 3,775.20 | 0.73% | 32.68 | 115.51 | 8,722 | 10.15% | 26.46% | 5,255.00 / 3,691.00 |
| 10 | SENORES SENORES PHARMACEUTICALS L | 1,335.30 | 3.64% | 49.39 | 27.03 | 6,150 | 11.45% | 93.48% | 1,599.00 / 684.60 |
| 11 | SMSPHARMA SMS Pharmaceuticals Limited | 470.95 | 1.19% | 42.23 | 11.15 | 4,411 | 32.98% | 98.04% | 494.45 / 245.21 |
| 12 | TTKHLTCARE TTK Healthcare Limited | 1,012.20 | 1.06% | 19.34 | 52.34 | 1,431 | 7.52% | 14.00% | 1,247.00 / 735.00 |